Implanet Announces The Appointment Of Brian T. Ennis To Head Its US Subsidiary

BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News:

IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants, announces the appointment of Brian T. Ennis as President of Implanet America. As such, he will head Implanet America and his objective will be to optimize its organisational structure in order to accelerate the JAZZ technology’s adoption and growth in this vital market.

MORE ON THIS TOPIC